JNJ - Mylan-Upjohn Merger And Other News: The Good Bad And Ugly Of Biopharma
Mylan Gets European Union Nod for Upjohn Merger
Mylan NV (MYL) reported that the European Union has given its approval to the company's merger with Pfizer’s (PFE) Upjohn. However, this antitrust clearance comes with certain caveats such as the offloading of certain assets. The European Commission underscored the point that Mylan and the Pfizer unit have overlap in several areas such as cardiovascular, urinary tract and nervous system therapeutics.
The European Commission stressed that its approval is conditional upon divestment of Mylan’s business for some generic drugs. Executive vice president Margrethe